Essilor Supports the Planned Friendly Bid for Sperian Protection
CHARENTON-LE-PONT,
Essilor International announced today that it has signed an agreement with
the Cinven Investment Fund and Mrs.
15.05% stake (23.21% voting rights) in Sperian Protection. According to the
terms of the deal and subject to certain conditions, Cinven will launch a
cash tender offer for Sperian Protection through a holding company (Menelas
France) under its control.
Essilor has agreed to tender all of its shares in Sperian Protection to
Menelas France, based on the offered price per share, provided that, at the
end of the offer period, Menelas France holds 57% of Sperian Protection’s
capital, including shares tendered by Essilor and Mrs.
By providing the resources needed to pursue growth opportunities when
they arise, Essilor believes this transaction is fully aligned with Sperian
Protection’s overall development strategy.
The world leader in ophthalmic optical products, Essilor International
researches, develops, manufactures and markets around the world a wide range
of lenses to correct myopia, hyperopia, presbyopia and astigmatism. Its
flagship brands are Varilux(R), Crizal(R), Essilor(R), Definity(R) and
Xperio(TM).
Based in
For more information, please visit http://www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is
included in the CAC 40 index.
Codes and symbols: ISIN: FR FR0000121667; Reuters: ESSI.PA; Bloomberg:
EI:FP.
Investor Relations and Financial Communications
Veronique Gillet - Sebastien Leroy
Phone: +33-(0)1-49-77-42-16
http://www.essilor.com
SOURCE Essilor